This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly in the production of active pharmaceutical ingredients (APIs) for medications targeting central nervous system disorders. It serves as a key intermediate in the development of drugs that modulate neurotransmitter activity, potentially aiding in the treatment of conditions like depression, anxiety, or Parkinson's disease. Its chiral structure is crucial for ensuring the efficacy and specificity of the final drug product. Additionally, it may be utilized in research settings to study the biochemical pathways involved in neurological diseases or to develop novel therapeutic agents. Its application is often focused on achieving high enantiomeric purity to meet regulatory and pharmacological standards.